| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 10/05/1999 | US5962658 (3-oxoisoindolin-1-ylidine)propandinitrile derivatives and method for preparing the same |
| 10/05/1999 | US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
| 10/05/1999 | US5962501 Headaches |
| 10/05/1999 | US5962498 Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
| 10/05/1999 | US5962473 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
| 10/05/1999 | US5962470 Heterocyclic compounds having anti-diabetic activity and their use |
| 10/05/1999 | US5962469 Cyclic nitrones |
| 10/05/1999 | US5962465 Brain disorders; psychological disorders |
| 10/05/1999 | CA2175204C Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 09/30/1999 | WO1999048869A1 Aryl phenyl substituted cyclic ketoenols |
| 09/30/1999 | WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 09/30/1999 | WO1999048522A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | DE19813354A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols |
| 09/30/1999 | CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
| 09/30/1999 | CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | CA2236827A1 Methods of identifying antagonists of glycosaminoglycan-protein interactions |
| 09/29/1999 | EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944597A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944596A1 Seco precursors of cyclopropylindolines and their use as prodrugs |
| 09/29/1999 | EP0944595A1 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 09/29/1999 | EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 09/29/1999 | EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 09/29/1999 | EP0944583A1 Novel compounds useful as therapeutic agents and assay reagents |
| 09/29/1999 | EP0944581A1 Process of preparing substituted acrylamides |
| 09/29/1999 | EP0944580A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis |
| 09/29/1999 | EP0553107B1 Protein kinase c modulators with anti-inflammatory and antiviral activity |
| 09/29/1999 | CN1230187A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230110A Cell adhesion inhibitors |
| 09/29/1999 | CN1045294C Method for prepn. of indole derivatives |
| 09/28/1999 | US5959146 Tricyclic compounds |
| 09/28/1999 | US5958965 4-aminoethoxy indoles |
| 09/28/1999 | US5958839 Herbicidal compounds |
| 09/28/1999 | US5958838 Controlling weeds in crops. |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | CA2181351C Process and intermediates for preparing naphthyridonecarboxylic acid salts |
| 09/23/1999 | WO1999047525A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 09/23/1999 | WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | WO1999047497A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | WO1999047490A1 Bicyclo[2.2.1]heptanes and related compounds |
| 09/23/1999 | CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942756A2 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation) |
| 09/22/1999 | EP0942728A1 Use of nk-1 receptor antagonists for treating sexual dysfunction |
| 09/22/1999 | CN1229082A Amine compound and its acid addition salt |
| 09/21/1999 | US5955501 Derived from phorboids of the diterpene- and benzolactam-classes. |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955491 Method for treating osteoporosis |
| 09/21/1999 | US5955487 Treating high blood pressure, cardiac insufficiency, glaucoma |
| 09/21/1999 | US5955462 Antiinflammatory agents for neurogenic inflammation and administering bisindole or compounds |
| 09/21/1999 | US5955435 Peptidyl compounds having MMP and TNF inhibitory activity |
| 09/21/1999 | US5955421 Peptides containing D-2-alkyl-Tryptophan |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046267A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | WO1999046244A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999046236A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | WO1999045968A1 Manganese chelates with high relaxivity in serum |
| 09/16/1999 | WO1999045967A1 Manganese chelates with high relaxivity in serum |
| 09/16/1999 | WO1999028304A9 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323472A1 Modulators of protein tyrosine phosphatases |
| 09/15/1999 | EP0941215A1 Glyoxylic acid amides and their use as pesticides |
| 09/15/1999 | EP0759899B1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228768A Insect-repellent formulation |
| 09/15/1999 | CN1228423A Process for preparation of optically active indoline-2-carboxylic acid or derivative thereof |
| 09/15/1999 | CN1228422A Process for preparing naphthyridones and intermediates |
| 09/15/1999 | CN1045101C Anilines as markers for mineral oils |
| 09/14/1999 | US5952527 A complex of transitional metal compound, cyclooctadiene or cyclopentadiene and 2,2-bis/diphenylphosphinoamino/-5,5',6,6'7,7',8,8'-octahydro-1 ,1'-binaphthyl compound; used as hydrogenation catalyst |
| 09/14/1999 | US5952511 Indolin-2-one derivatives |
| 09/14/1999 | US5952497 N.sup.α -Bpoc amino acid pentafluorophenyl (Pfp) esters and 3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl (ODhbt) esters |
| 09/14/1999 | US5952386 Excellent insecticidal activity for the control of noxious insects |
| 09/14/1999 | US5952377 Fatty acid analogs and prodrugs |
| 09/14/1999 | US5952365 2- 2-(Dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro 4.5!decane dimaleate |
| 09/14/1999 | US5952362 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxyphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 09/14/1999 | US5952355 Propenone derivatives |
| 09/14/1999 | US5952343 HIV protease inhibitors |
| 09/14/1999 | US5952322 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| 09/14/1999 | CA2006356C Arylpiperazinylbutyl-dihydroindoles and related compounds |
| 09/14/1999 | CA1340734C Substituted bridged-diazabicycloalkyl quinolone carboxylic acids |
| 09/10/1999 | WO1999044989A1 Matrix metalloproteinase inhibitors |
| 09/10/1999 | WO1999044987A1 NON-PEPTIDE GnRH AGENTS |
| 09/10/1999 | WO1999044624A2 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999044608A1 New use |
| 09/10/1999 | CA2322854A1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 09/10/1999 | CA2322444A1 Non-peptide gnrh agents |
| 09/10/1999 | CA2320757A1 New use |
| 09/10/1999 | CA2317502A1 Matrix metalloproteinase inhibitors |
| 09/08/1999 | EP0940139A2 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
| 09/08/1999 | EP0939627A1 Pentafluorobenzenesulfonamides and analogs |
| 09/08/1999 | CN1228094A Palladium catalyzed indolization |
| 09/07/1999 | US5948816 Non-tolerance-inducing antiviral agents |
| 09/07/1999 | US5948808 Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens |
| 09/07/1999 | US5948807 Spiroindanamines and Spiroindanimides |
| 09/07/1999 | US5948780 Administering a metalloproteinase inhibitor |
| 09/07/1999 | US5948600 Method and material for the formation of a heat mode image |
| 09/07/1999 | US5948593 Optical recording medium |